356 related articles for article (PubMed ID: 28406579)
1. Disparities in pharmacotherapy for alcohol use disorder in the context of universal health care: a Swedish register study.
Karriker-Jaffe KJ; Ji J; Sundquist J; Kendler KS; Sundquist K
Addiction; 2017 Aug; 112(8):1386-1394. PubMed ID: 28406579
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden.
Månsson A; Danielsson AK; Sjöqvist H; Glatz T; Lundin A; Wallhed Finn S
Addict Sci Clin Pract; 2024 May; 19(1):41. PubMed ID: 38764075
[TBL] [Abstract][Full Text] [Related]
3. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic and geographic disparities in access to pharmacotherapy for alcohol dependence.
Morley KC; Logge W; Pearson SA; Baillie A; Haber PS
J Subst Abuse Treat; 2017 Mar; 74():23-25. PubMed ID: 28132696
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for alcohol use disorders - Unequal provision across sociodemographic factors and co-morbid conditions. A cohort study of the total population in Sweden.
Wallhed Finn S; Lundin A; Sjöqvist H; Danielsson AK
Drug Alcohol Depend; 2021 Oct; 227():108964. PubMed ID: 34518028
[TBL] [Abstract][Full Text] [Related]
6. Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
Carlsson AC; Wändell P; Gasevic D; Sundquist J; Sundquist K
Int J Cardiol; 2015; 187():547-52. PubMed ID: 25863300
[TBL] [Abstract][Full Text] [Related]
7. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
Buri C; Moggi F; Giovanoli A; Strik W
Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
[TBL] [Abstract][Full Text] [Related]
8. Substance use disorders in refugee and migrant groups in Sweden: A nationwide cohort study of 1.2 million people.
Harris S; Dykxhoorn J; Hollander AC; Dalman C; Kirkbride JB
PLoS Med; 2019 Nov; 16(11):e1002944. PubMed ID: 31689291
[TBL] [Abstract][Full Text] [Related]
9. Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study.
Thompson A; Ashcroft DM; Owens L; van Staa TP; Pirmohamed M
PLoS One; 2017; 12(3):e0173272. PubMed ID: 28319159
[TBL] [Abstract][Full Text] [Related]
10. Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration.
Taylor E; Timko C; Harris AHS; Yu M; Finlay AK
Addict Sci Clin Pract; 2019 Jan; 14(1):1. PubMed ID: 30602392
[TBL] [Abstract][Full Text] [Related]
11. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
Williams EC; Matson TE; Harris AHS
Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
[TBL] [Abstract][Full Text] [Related]
12. Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review.
Hyland CJ; McDowell MJ; Bain PA; Huskamp HA; Busch AB
J Subst Abuse Treat; 2023 Jan; 144():108919. PubMed ID: 36332528
[TBL] [Abstract][Full Text] [Related]
13. Chains of risk for alcohol use disorder: Mediators of exposure to neighborhood deprivation in early and middle childhood.
Karriker-Jaffe KJ; Lönn SL; Cook WK; Kendler KS; Sundquist K
Health Place; 2018 Mar; 50():16-26. PubMed ID: 29334617
[TBL] [Abstract][Full Text] [Related]
14. Not in education, employment, or training (NEET) and risk of alcohol use disorder: a nationwide register-linkage study with 485 839 Swedish youths.
Manhica H; Lundin A; Danielsson AK
BMJ Open; 2019 Oct; 9(10):e032888. PubMed ID: 31615804
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the Variation of Alcohol Cessation Pharmacotherapy in Primary Care.
Bernstein E; Guo N; Goto T; Rothberg MB
J Gen Intern Med; 2021 Jul; 36(7):1989-1996. PubMed ID: 33515195
[TBL] [Abstract][Full Text] [Related]
16. Different Characteristics and Heritabilities of Alcohol Use Disorder Classes: A Population-Based Swedish Study.
Long EC; Ohlsson H; Sundquist J; Sundquist K; Kendler KS
Alcohol Alcohol; 2019 Dec; 54(6):647-655. PubMed ID: 31556919
[TBL] [Abstract][Full Text] [Related]
17. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
[TBL] [Abstract][Full Text] [Related]
18. Neighbourhood deprivation and hospitalization for atrial fibrillation in Sweden.
Zöller B; Li X; Sundquist J; Sundquist K
Europace; 2013 Aug; 15(8):1119-27. PubMed ID: 23447572
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic Inequalities in the Prescription of Oral Anticoagulants in Stroke Patients With Atrial Fibrillation.
Sjölander M; Eriksson M; Asplund K; Norrving B; Glader EL
Stroke; 2015 Aug; 46(8):2220-5. PubMed ID: 26081841
[TBL] [Abstract][Full Text] [Related]
20. Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada: A whole-population cohort study.
Konrad G; Leong C; Bolton JM; Prior HJ; Paillé MT; Nepon J; Singal D; Ekuma O; Enns JE; Nickel NC
PLoS One; 2021; 16(9):e0257025. PubMed ID: 34478448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
